ExploreWatchlistsPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash from financing

Daito Pharmaceutical Co., Ltd. (4577)

Market cap
¥41.1B
P/E ratio
16.2x
Daito manufactures active pharmaceutical ingredients and prescription drugs for domestic and international pharmaceutical companies. The company offers an integrated production system from raw materials to final formulations.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
May 31, 20251,002-647.54%
May 31, 2024-183-129.71%
May 31, 2023616-37.71%
May 31, 2022989-30.58%
May 31, 20211,425-506.54%
May 31, 2020-350-87.91%
May 31, 2019-2,898+87.75%
May 31, 2018-1,544-13.17%
May 31, 2017-1,778-437.77%
May 31, 2016526+4.66%
May 31, 2015503

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat